Ticker News
$ZETA News
Stored TradersLink news articles and press-release context for this ticker. Discord alerts link into these article pages when full article text is available.
Published Articles
Latest saved alerts
ZETA registers 287,711-share resale; will issue up to $1.25M of Class A over several quarters for services
ZETA filed SEC Form 424B5. Selling stockholders’ 287,711 Class A shares (from the Senso acquisition) are registered for resale and may be sold into the market from time to time, creating immediate resale overhang. Separately, Zeta will issue up to $1,250,000 of Class A common stock to a service provider over the next several fiscal quarters as payments become due, which will dilute existing holders when each issuance occurs. The number of shares issued for each payment will be calculated by dividing the dollar amount due by the 5‑day VWAP ending the trading day before each payment date (i.e., issuance price tied to 5‑day VWAP).
Expedition Therapeutics raises $115M Series B; ZETA CEO to discuss Q2 beat-and-raise
Expedition Therapeutics secured a $115 million Series B and says first patients have been dosed in its Phase 2 trial of EXPD-101 for COPD, marking both a financing and clinical progress milestone. Separately, Zeta Global (ZETA) CEO will appear on NYSE Live to discuss the company's Q2 report, which Zeta said was its 20th consecutive 'beat-and-raise' quarter and achieved the firm’s cited 'Rule of 64.'